Akebia Therapeutics, Inc. granted five newly-hired employees options to purchase an aggregate of 49,650 shares of Akebia’s common stock on November 30, 2018, as inducements material to each such employee’s entering into employment with Akebia. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
December 3, 2018
· 1 min read